Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 3Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Sleep Apnea, Obstructive 1Skin Diseases 1Polycythemia Vera 1Neoplasms by Site 1Gliosarcoma 1Glioblastoma 1Breast Neoplasms 1Breast Diseases 1Brain Neoplasms 1Body Weight Changes 1Anorexia 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of the Prostate 1Adenocarcinoma of Lung 1

Interventions

Temozolomide 19Radiotherapy 11Bevacizumab 7Radiation 4Irinotecan 4Erlotinib Hydrochloride 4carmustine, poliferprosan 20 drug combination 3Radiotherapy, Intensity-Modulated 3O(6)-benzylguanine 3Magnetic Resonance Spectroscopy 3Carmustine 32,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3Vorinostat 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Radiosurgery 2Gadolinium DTPA 2Filgrastim 2Drug Therapy 2Congresses as Topic 2Cilengitide 2Chemotherapy, Adjuvant 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vitespin 1sargramostim 1sapanisertib 1poly ICLC 1plerixafor 1picropodophyllin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Gliosarcoma × Watchful Waiting × Clear all
NCT01122888 2015-04-28

Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 1 Terminated
41 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡